Abstract
Tranexamic acid (TXA) is widely used in various surgical settings to prevent bleeding. Despite extensive evidence supporting its safety and efficacy in many procedures, including hip fracture surgery, it is still largely underused. TXA could be given orally, intravenously or topically pre-, intra- and/or postoperatively. It has been shown to reduce blood transfusions and also to shorten hospital stays. Low doses are efficient. Almost all patients with hip fracture should receive TXA.
References
Downloads
pdf
Authors
Sigismond Lasocki Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France
Maëva Campfort
Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France
Maxime Léger
Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France
Emmanuel Rineau
Département Anesthésie Réanimation, CHU Angers, Université d’Angers, Angers, France
- Abstract viewed - 1063 times
- pdf downloaded - 0 times